AVIR EBITDA Growth
Atea Pharmaceuticals Inc · EBITDA Growth
AVIR EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-22.97%period ending
AVIR TTM EBITDA YoY % (24.44% → -22.97%)
Year-over-year change
High-resolution chart · PNG
AVIR ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -22.97% | |
| -30.1477% | |
| -0.8852% | |
| 12.9417% | |
| 19.108% | |
| 14.3155% | |
| -25.0262% | |
| -41.5744% | |
| -67.0406% | |
| -53.4747% | |
| -19.3129% | |
| -436.7087% | |
| -498.0548% | |
| -259.6622% | |
| -180.8366% | |
| -4.6636% | |
| -38.9462% | |
| 177.8533% | |
| 1,364.9352% | |
| 204.7355% | |
| 289.4638% | |
| 247.0274% | |
| 24.4395% |